Under the terms of the letter of agreement, which was signed on 9 December, the HMS’s Central Europe Clinical Scholars Research Training program will start in July 2023 and run through June 2026.
The US institution will be responsible for the curriculum and delivery of the training. Semmelweis University (SE) will contribute 50 per cent of the tuition costs for 50 participants in each annual program, or $250,000 per year for this purpose. The program is also open to candidates from neighbouring countries in the Central and Eastern European region – SE said in a press release.
The curriculum will help participants to develop skills essential to pursue high-quality clinical research, including epidemiology, biostatistics, ethics, and leadership.
Students enrolled in the nine-month program will participate in live workshops and webinars, complete individual and team assignments, and independently engage with hours of on-demand, recorded lectures.
Participants who have satisfactorily completed the program requirements shall receive a Certificate of Completion signed by the course director(s).
HMS chose the SE for a reason: as we wrote in the autumn, Semmelweis became the first Hungarian university to be ranked among the top 250 universities in the world by Times Higher Education (THE). We reported also earlier that in the US News Best Global Universities 2023 ranking, Semmelweis University has moved up 12 positions from last year’s ranking in cardiology and cardiovascular systems, to 43rd position.